---
figid: PMC3942883__nihms561863f1
figlink: /pmc/articles/PMC3942883/figure/F1/
number: F1
caption: Induction and clearance strategies. (a) Induction. Several small molecules
  have been identified that are able to induce transcription of quiescent HIV proviruses.
  Prostratin, tumor necrosis factor-α, and bryostatin have been demonstrated to act
  on the protein kinase C/nuclear factor κB (PKC/NF-κB) pathway. Activated PKC phosphorylates
  IκBα, causing release of NF-κB. NF-κB then translocates to the nucleus, where it
  binds to the promoter of HIV and promotes transcription. Histone deacetylase (HDAC)
  inhibitors directly inhibit deacetylation of histones at the HIV long terminal repeat
  (LTR), which is associated with induction of transcription. Similarly, histone methyltransferase
  inhibitors (HMTi) inhibit the methylation of histone tails, which are associated
  with transcription from the HIV promoter in some model systems. Hexamethylene bisacetamide
  (HMBA) causes activation of the Akt pathway, which may result in phosphorylation
  of HMBA inducible 1 (HEXIM). This may result in the release of positive transcription
  elongation factor b (p-TEFb) from the inhibitory HEXIM complex, allowing p-TEFb
  access to the HIV LTR, where it phosphorylates RNA pol II and primes the LTR for
  transcription. Disulfiram has been shown to act upstream of HMBA, perhaps by causing
  degradation of phosphatase and tensin homolog, an inhibitor of AKT. Activated AKT
  then phosphorylates HEXIM, and LTR induction ensues. Vaccination may activate some
  T cells, inducing transcription from quiescent HIV LTRs. (b) Clearance. Once viral
  transcription has been induced, cells containing HIV must be cleared. There are
  several mechanisms that may contribute to clearance. If HIV transcription is sufficient
  to produce HIV protein, HIV antigens may be displayed on the cell surface, which
  may allow the immune system to target and destroy the infected cells. Alternatively,
  the cell may undergo apoptosis in response to HIV production. Antiretroviral therapy
  (ART) will be used to prevent de novo infection.
pmcid: PMC3942883
papertitle: Prospects for Treatment of Latent HIV.
reftext: KM Barton, et al. Clin Pharmacol Ther. ;93(1):46-56.
pmc_ranked_result_index: '222751'
pathway_score: 0.9539847
filename: nihms561863f1.jpg
figtitle: Induction and clearance strategies
year: ''
organisms: Homo sapiens
ndex: 1237c990-deee-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3942883__nihms561863f1.html
  '@type': Dataset
  description: Induction and clearance strategies. (a) Induction. Several small molecules
    have been identified that are able to induce transcription of quiescent HIV proviruses.
    Prostratin, tumor necrosis factor-α, and bryostatin have been demonstrated to
    act on the protein kinase C/nuclear factor κB (PKC/NF-κB) pathway. Activated PKC
    phosphorylates IκBα, causing release of NF-κB. NF-κB then translocates to the
    nucleus, where it binds to the promoter of HIV and promotes transcription. Histone
    deacetylase (HDAC) inhibitors directly inhibit deacetylation of histones at the
    HIV long terminal repeat (LTR), which is associated with induction of transcription.
    Similarly, histone methyltransferase inhibitors (HMTi) inhibit the methylation
    of histone tails, which are associated with transcription from the HIV promoter
    in some model systems. Hexamethylene bisacetamide (HMBA) causes activation of
    the Akt pathway, which may result in phosphorylation of HMBA inducible 1 (HEXIM).
    This may result in the release of positive transcription elongation factor b (p-TEFb)
    from the inhibitory HEXIM complex, allowing p-TEFb access to the HIV LTR, where
    it phosphorylates RNA pol II and primes the LTR for transcription. Disulfiram
    has been shown to act upstream of HMBA, perhaps by causing degradation of phosphatase
    and tensin homolog, an inhibitor of AKT. Activated AKT then phosphorylates HEXIM,
    and LTR induction ensues. Vaccination may activate some T cells, inducing transcription
    from quiescent HIV LTRs. (b) Clearance. Once viral transcription has been induced,
    cells containing HIV must be cleared. There are several mechanisms that may contribute
    to clearance. If HIV transcription is sufficient to produce HIV protein, HIV antigens
    may be displayed on the cell surface, which may allow the immune system to target
    and destroy the infected cells. Alternatively, the cell may undergo apoptosis
    in response to HIV production. Antiretroviral therapy (ART) will be used to prevent
    de novo infection.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT3
  - AKT1
  - ADCY4
  - HDAC5
  - ADCY1
  - ADCY2
  - ADCY3
  - AGRP
  - HDAC6
  - SIRT2
  - ADCY9
  - ADCY10
  - PRKCI
  - HDAC2
  - SIRT7
  - SIRT6
  - AKT2
  - CCNT1
  - MB
  - PRKD3
  - SIRT5
  - ADCY7
  - SIRT4
  - SIRT3
  - SIRT1
  - HDAC8
  - HDAC1
  - PRKCQ
  - CCNT2
  - CDK9
  - CCNK
  - PTEN
  - ADCY8
  - ADCY6
  - PRKCB
  - PRKCD
  - PRKCZ
  - PRKCG
  - PRKCH
  - HDAC3
  - NFKBIA
  - NFKB1
  - HDAC7
  - HDAC9
  - ADCY5
  - PRKCA
  - HDAC10
  - PRKCE
  - HDAC11
  - HDAC4
  - Disulfiram
  - Cancer
genes:
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY4
  entrez: '196883'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC5
  entrez: '10014'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY1
  entrez: '107'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY2
  entrez: '108'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY3
  entrez: '109'
- word: ART
  symbol: ART
  source: hgnc_alias_symbol
  hgnc_symbol: AGRP
  entrez: '181'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC6
  entrez: '10013'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT2
  entrez: '22933'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY9
  entrez: '115'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY10
  entrez: '55811'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC2
  entrez: '3066'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT7
  entrez: '51547'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT6
  entrez: '51548'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: P-TEFB
  symbol: PTEFb
  source: bioentities_symbol
  hgnc_symbol: CCNT1
  entrez: '904'
- word: НMBА
  symbol: MB
  source: hgnc_symbol
  hgnc_symbol: MB
  entrez: '4151'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT5
  entrez: '23408'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY7
  entrez: '113'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT4
  entrez: '23409'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT3
  entrez: '23410'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT1
  entrez: '23411'
- word: HDACI
  symbol: HDAC_I
  source: bioentities_symbol
  hgnc_symbol: HDAC8
  entrez: '55869'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC1
  entrez: '3065'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: P-TEFB
  symbol: PTEFb
  source: bioentities_symbol
  hgnc_symbol: CCNT2
  entrez: '905'
- word: P-TEFB
  symbol: PTEFb
  source: bioentities_symbol
  hgnc_symbol: CDK9
  entrez: '1025'
- word: P-TEFB
  symbol: PTEFb
  source: bioentities_symbol
  hgnc_symbol: CCNK
  entrez: '8812'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY8
  entrez: '114'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY6
  entrez: '112'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: HDACI
  symbol: HDAC_I
  source: bioentities_symbol
  hgnc_symbol: HDAC2
  entrez: '3066'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC3
  entrez: '8841'
- word: HDACI
  symbol: HDAC_I
  source: bioentities_symbol
  hgnc_symbol: HDAC3
  entrez: '8841'
- word: Ikba
  symbol: IkappaBalpha
  source: hgnc_alias_symbol
  hgnc_symbol: NFKBIA
  entrez: '4792'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC7
  entrez: '51564'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC9
  entrez: '9734'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY5
  entrez: '111'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC10
  entrez: '83933'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC8
  entrez: '55869'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: HDACI
  symbol: HDAC_I
  source: bioentities_symbol
  hgnc_symbol: HDAC1
  entrez: '3065'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC11
  entrez: '79885'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC4
  entrez: '9759'
chemicals:
- word: Disulfiram
  source: MESH
  identifier: D004221
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC3942883__F1
redirect_from: /figures/PMC3942883__F1
figtype: Figure
---
